LexDanaLexDanabeta
Inventor

Murielle DERRIEN

Inventor
FR

Overview

2→
Patents
2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes25%
PatentTitleYear
12,133,867Universal anti-CD22 chimeric antigen receptor engineered immune cells202411,944,643Universal anti-CD22 chimeric antigen receptor engineered immune cells2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to CELLECTIS SA (2)· patent assignee history
2024Based in FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CELLECTIS SA22024
Locations
LocationPatentsSpan
FR22024